Pharmaceutical Chemistry
The study of creating biologically active compounds and medications for medicinal purposes is known as pharmaceutical chemistry. Its roots can be found at the intersection of chemistry, science, and pharmacology. Discovering, creating, and developing novel chemical compounds that can be utilised therapeutically is the primary objective of pharmaceutical chemistry. This includes studies on currently accessible drugs, their biological properties, and the relationship between action and quantitative structure.
Related Conference of Pharmaceutical Chemistry
Pharmaceutical Chemistry Conference Speakers
Recommended Sessions
- Pharmacology
- Adverse drug reactions
- Autonomic Pharmacology
- Cardiovascular Pharmacology
- Clinical Pharmacology
- Drug Discovery and Drug Screening
- Environmental Pharmacology
- Ethnopharmacology
- Forensic Toxicology
- Genetic Toxicology
- Neuropharmacology
- Nursing Pharmacology
- Pharmaceutical Chemistry
- Pharmacodynamics
- Pharmacokinetics
- Pharmacological Testing
- Psychopharmacology
- Toxicology
Related Journals
Are you interested in
- Advanced Diagnostics & Biomarkers - PHARMACY CONGRESS 2025 (Italy)
- Advanced Drug Delivery Systems - PHARMACY CONGRESS 2025 (Italy)
- Advanced Drug Delivery Systems - BIOMEDICINE 2025 (UAE)
- Advances in Omics Technologies - BIOMEDICINE 2025 (UAE)
- Advances in Pain Management - PHARMACY CONGRESS 2025 (Italy)
- Advances in Vaccine Technology - BIOMEDICINE 2025 (UAE)
- Alzheimer’s and Parkinson’s Diseases - Neuropharmaceutics 2025 (UAE)
- Antimicrobial Therapy & Resistance - PHARMACY CONGRESS 2025 (Italy)
- Artificial Intelligence in Biomedicine - BIOMEDICINE 2025 (UAE)
- Biologics & Biosimilars - PHARMACY CONGRESS 2025 (Italy)
- Biotechnology in Drug Development - BIOMEDICINE 2025 (UAE)
- Brain Injury and Behavioral Neuroscience - Neuropharmaceutics 2025 (UAE)
- Brain Pathology and Oncology Research - Neuropharmaceutics 2025 (UAE)
- Brain Stimulation and Imaging - Neuropharmaceutics 2025 (UAE)
- Brain Structure and Function - Neuropharmaceutics 2025 (UAE)
- Cardiovascular Pharmacotherapy - BIOMEDICINE 2025 (UAE)
- Case Reports: Unusual Adverse Drug Reactions - PHARMACY CONGRESS 2025 (Italy)
- Clinical Neurophysiology and Stroke - Neuropharmaceutics 2025 (UAE)
- Clinical Pharmacology and Therapeutics - BIOMEDICINE 2025 (UAE)
- Clinical Trials for Rare Diseases - PHARMACY CONGRESS 2025 (Italy)
- CNS and Brain Disorders - Neuropharmaceutics 2025 (UAE)
- Cognitive Neuroscience and Psychology - Neuropharmaceutics 2025 (UAE)
- Cutting-Edge Formulation Strategies - PHARMACY CONGRESS 2025 (Italy)
- Digital Health and Telemedicine - BIOMEDICINE 2025 (UAE)
- Digital Health Technologies Integration - PHARMACY CONGRESS 2025 (Italy)
- Ethical Challenges and Regulatory Science in Healthcare and Pharmaceuticals - BIOMEDICINE 2025 (UAE)
- Gene Therapy and Genetic Medicine - BIOMEDICINE 2025 (UAE)
- Human Brain Mapping - Neuropharmaceutics 2025 (UAE)
- Immunotherapy and Immunopharmacology - BIOMEDICINE 2025 (UAE)
- Infectious Diseases and Antimicrobial Resistance - BIOMEDICINE 2025 (UAE)
- Innovations in Biologics and Biosimilars - BIOMEDICINE 2025 (UAE)
- Innovations in Clinical Trials - PHARMACY CONGRESS 2025 (Italy)
- Metabolic Disorders and Endocrinology - BIOMEDICINE 2025 (UAE)
- Molecular and cellular neurochemistry - Neuropharmaceutics 2025 (UAE)
- Nanotechnology in Biomedicine - BIOMEDICINE 2025 (UAE)
- Neurobiology and Behaviors - Neuropharmaceutics 2025 (UAE)
- Neurogenesis - Neuropharmaceutics 2025 (UAE)
- Neuroimmunology and Neurological Infections - Neuropharmaceutics 2025 (UAE)
- Neuroinformatics and Computational Neuroscience - Neuropharmaceutics 2025 (UAE)
- Neurological Disorders and Stroke - Neuropharmaceutics 2025 (UAE)
- Neuropharmacology and genetic aspects of CNS function - Neuropharmaceutics 2025 (UAE)
- Neuropharmacology and Neurochemistry - Neuropharmaceutics 2025 (UAE)
- Neuropharmacology and Neurotherapeutics - BIOMEDICINE 2025 (UAE)
- Neurorehabilitation and Neural Repair - Neuropharmaceutics 2025 (UAE)
- Neuroscience and Artificial Intelligence - Neuropharmaceutics 2025 (UAE)
- Neurotherapeutics and Case Studies - Neuropharmaceutics 2025 (UAE)
- Nutraceuticals & Herbal Medicines - PHARMACY CONGRESS 2025 (Italy)
- Oncology Research and Therapeutics - BIOMEDICINE 2025 (UAE)
- Paediatric & Geriatric Pharmaceutical Innovations - PHARMACY CONGRESS 2025 (Italy)
- Paediatric and Geriatric Pharmacotherapy - BIOMEDICINE 2025 (UAE)
- Pharmaceutical Biotechnology - PHARMACY CONGRESS 2025 (Italy)
- Pharmaceutical Ethics & Compliance - PHARMACY CONGRESS 2025 (Italy)
- Pharmaceutical Policy & Health Economics - PHARMACY CONGRESS 2025 (Italy)
- Pharmacogenomics & Personalized Medicine - PHARMACY CONGRESS 2025 (Italy)
- Pharmacogenomics and Personalized Medicine - BIOMEDICINE 2025 (UAE)
- Pharmacological Interventions for Mental Health - PHARMACY CONGRESS 2025 (Italy)
- Pharmacovigilance & Drug Safety - PHARMACY CONGRESS 2025 (Italy)
- Pharmacovigilance and Drug Safety - BIOMEDICINE 2025 (UAE)
- Pharmacy Informatics - PHARMACY CONGRESS 2025 (Italy)
- Pre- and post-synaptic function - Neuropharmaceutics 2025 (UAE)
- Public Health and Pharmacoeconomics - BIOMEDICINE 2025 (UAE)
- Rare and Orphan Diseases: Therapeutic Approaches - BIOMEDICINE 2025 (UAE)
- Rare Disease Therapeutics - BIOMEDICINE 2025 (UAE)
- Regenerative Medicine and Tissue Engineering - BIOMEDICINE 2025 (UAE)
- Regulatory Affairs & Drug Approval - PHARMACY CONGRESS 2025 (Italy)
- Respiratory and Pulmonary Pharmacotherapy - BIOMEDICINE 2025 (UAE)
- Stem Cells Role in Neuro-Biological Treatment - Neuropharmaceutics 2025 (UAE)
- Synapse formation and neurotransmitter receptors - Neuropharmaceutics 2025 (UAE)
- Synaptic Function and Dysfunction in Brain Diseases - Neuropharmaceutics 2025 (UAE)
- Synaptic plasticity and memory - Neuropharmaceutics 2025 (UAE)